Cardiotoxicity of Tyrosine-Kinase-Targeting Drugs

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 8, Iss. 1, 2010-01 ,pp. : 11-21

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Agents Targeting Nitric Oxide

By  

Current Vascular Pharmacology, Vol. 10, Iss. 1, 2012-01 ,pp. : 61-76

Bentham Science Publishers

Access to resources Recommend Favorite

Are fertility drugs a risk factor for persistent trophoblastic tumour?

By Petignat Patrick   Vassilakos Pierre   Campana Aldo  

Human Reproduction, Vol. 17, Iss. 6, 2002-06 ,pp. : 1610-1615

Oxford University Press

Access to resources Recommend Favorite

Vascular Targeting Agents: Therapeutics and Diagnostic Development

By  

Angiogenesis, Vol. 7, Iss. 2, 2004-01 ,pp. : 189-189

Springer Publishing Company

Access to resources Recommend Favorite

Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis

By Hishitani Y   Ogata A   Shima Y   Hirano T   Ebina K   Kunugiza Y   Shi K   Narazaki M   Hagihara K   Tomita T   Yoshikawa H   Tanaka T   Kumanogoh A  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. : 253-259

Informa Healthcare

Access to resources Recommend Favorite